amitriptyline has been researched along with Nausea in 15 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
Nausea: An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fluoxetine, a specific serotonin reuptake inhibitor, was compared to amitriptyline in the treatment of 51 outpatients with primary major depressive disorder." | 9.05 | A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder. ( Chouinard, G, 1985) |
| "The efficacy and safety of fluoxetine, a new antidepressant agent, were assessed in a double-blind, parallel, randomized study of 44 outpatients with major depressive disorder." | 9.05 | A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder. ( Feighner, JP, 1985) |
| "Headache is one of the most frequently reported symptoms in post-COVID patients." | 5.72 | Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors. ( Arias-Rivas, S; Gago-Veiga, AB; García-Azorín, D; Gonzalez-Martinez, A; Guerrero-Peral, ÁL; Sierra, Á; Silva, L, 2022) |
| "Fluoxetine, a specific serotonin reuptake inhibitor, was compared to amitriptyline in the treatment of 51 outpatients with primary major depressive disorder." | 5.05 | A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder. ( Chouinard, G, 1985) |
| "The efficacy and safety of fluoxetine, a new antidepressant agent, were assessed in a double-blind, parallel, randomized study of 44 outpatients with major depressive disorder." | 5.05 | A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder. ( Feighner, JP, 1985) |
| " On the other hand, patients with divalproex exhibited significantly higher risk of nausea compared to those with placebo, topiramate, propranolol, gabapentin and amitriptyline." | 4.95 | Unveiling the relative efficacy, safety and tolerability of prophylactic medications for migraine: pairwise and network-meta analysis. ( He, A; Li, C; Song, D; Zhang, L, 2017) |
| "Headache is one of the most frequently reported symptoms in post-COVID patients." | 1.72 | Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors. ( Arias-Rivas, S; Gago-Veiga, AB; García-Azorín, D; Gonzalez-Martinez, A; Guerrero-Peral, ÁL; Sierra, Á; Silva, L, 2022) |
| "Chronic nausea is a major, disabling symptom that requires increased recognition as a separate functional entity." | 1.40 | Chronic idiopathic nausea of childhood. ( Chelimsky, G; Kovacic, K; Li, BU; Miranda, A; Simpson, P; Williams, S, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (53.33) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gonzalez-Martinez, A | 1 |
| Guerrero-Peral, ÁL | 1 |
| Arias-Rivas, S | 1 |
| Silva, L | 1 |
| Sierra, Á | 1 |
| Gago-Veiga, AB | 1 |
| García-Azorín, D | 1 |
| Martin, CM | 1 |
| Keller, K | 1 |
| Beule, J | 1 |
| Dippold, W | 1 |
| Kovacic, K | 1 |
| Miranda, A | 1 |
| Chelimsky, G | 1 |
| Williams, S | 1 |
| Simpson, P | 1 |
| Li, BU | 1 |
| He, A | 1 |
| Song, D | 1 |
| Zhang, L | 1 |
| Li, C | 1 |
| Liao, KY | 1 |
| Chang, FY | 1 |
| Wu, LT | 1 |
| Wu, TC | 1 |
| VERGA, G | 1 |
| Guy, W | 1 |
| Ban, TA | 1 |
| McEvoy, JP | 1 |
| Petrie, WM | 1 |
| Wilson, WH | 1 |
| Schaffer, JD | 1 |
| Gualtieri, CT | 1 |
| Staye, J | 1 |
| Martin, M | 1 |
| Diaz-Rubio, E | 1 |
| Casado, A | 1 |
| Dominguez, S | 1 |
| Sastre, J | 1 |
| Chouinard, G | 1 |
| Feighner, JP | 1 |
| Kabes, J | 1 |
| Taussigová, D | 1 |
| Dostál, T | 1 |
| Vinar, O | 1 |
| Gayford, JJ | 1 |
| Redpath, TH | 1 |
| Gannon, P | 1 |
| Itil, T | 1 |
| Keskiner, A | 1 |
| Hsu, B | 1 |
2 reviews available for amitriptyline and Nausea
| Article | Year |
|---|---|
Unveiling the relative efficacy, safety and tolerability of prophylactic medications for migraine: pairwise and network-meta analysis.
Topics: Adult; Amines; Amitriptyline; Anticonvulsants; Cyclohexanecarboxylic Acids; Dizziness; Female; Fruct | 2017 |
The side-effects of carbamazepine.
Topics: Amitriptyline; Anemia, Aplastic; Carbamazepine; Dibenzazepines; Gastrointestinal Diseases; Humans; I | 1969 |
4 trials available for amitriptyline and Nausea
| Article | Year |
|---|---|
A collaborative study of a new antidepressant, viloxazine, in neurotic and endogenous depressives.
Topics: Adolescent; Adult; Amitriptyline; Clinical Trials as Topic; Depressive Disorder; Dizziness; Doxepin; | 1982 |
A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder.
Topics: Adult; Ambulatory Care; Amitriptyline; Anxiety; Body Weight; Clinical Trials as Topic; Depressive Di | 1985 |
A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder.
Topics: Adult; Aged; Akathisia, Drug-Induced; Ambulatory Care; Amitriptyline; Clinical Trials as Topic; Depr | 1985 |
Clinical and quantitative electroencephalographical effects of MK 940.
Topics: Adjustment Disorders; Adult; Amitriptyline; Anorexia Nervosa; Attention; Clinical Trials as Topic; C | 1970 |
9 other studies available for amitriptyline and Nausea
| Article | Year |
|---|---|
Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors.
Topics: Amitriptyline; COVID-19; Female; Headache; Humans; Male; Migraine Disorders; Nausea; Retrospective S | 2022 |
Lessons learned from hospice care.
Topics: Aged; Aged, 80 and over; Amitriptyline; Analgesics, Opioid; Drug Monitoring; Fentanyl; Health Servic | 2013 |
Cyclic vomiting syndrome in adults.
Topics: Abdominal Pain; Adult; Amitriptyline; Antiemetics; Combined Modality Therapy; Diagnosis, Differentia | 2013 |
Chronic idiopathic nausea of childhood.
Topics: Abdominal Pain; Adolescent; Amitriptyline; Antidepressive Agents, Tricyclic; Anxiety; Child; Chronic | 2014 |
Cyclic vomiting syndrome in Taiwanese children.
Topics: Adolescent; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Age of Onset; Amitriptyline; | 2011 |
[AMITRIPTYLINE IN AMBULATORY PSYCHIATRIC PRACTICE].
Topics: Amitriptyline; Autonomic Nervous System Diseases; Depression; Drug Eruptions; Drug Hypersensitivity; | 1964 |
Withdrawal symptoms after abrupt cessation of amitriptyline in an eight-year-old boy.
Topics: Amitriptyline; Child; Humans; Hyperkinesis; Male; Nausea; Substance Withdrawal Syndrome | 1979 |
Progressive loss of antiemetic efficacy during subsequent courses of chemotherapy.
Topics: Adult; Aged; Amitriptyline; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cyclophosph | 1992 |
L-dopa and tricyclic antidepressants in affective disorders. A pilot study.
Topics: Adult; Amitriptyline; Depression; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Levodo | 1974 |